In uraemic patients, cyanide detoxication capability is impaired because of a reduced SCN- clearance, and increased cyanocobalamin synthesis indicates elevation of cyanide pool, which would be related to the development of uraemic neuropathy. Methylcobalamin was considered to be utilized in cyanide detoxication process via cyanocobalamin synthesis.
No takes yet. Share an insight, caveat, or question.
Koyama et al. (1997) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: